Manufacturing

Petrovax’s biotechnological manufacturing and warehouse complex was opened in the Moscow region in 2008.

manufacturing facilities include 4 production lines

The manufacturing processes include the synthesis of APIs, the production of sterile and non-sterile medicines, including immunological and biopharmaceutical drugs in various dosage forms. Manufacturing capacity is more than 160 million doses of products per year. The company owns a pharmaceutical warehouse that provides appropriate storage conditions for medicinal products.

Line 1

the release of medicines in pre-filled syringes
Line 2

manufacturing of medicines for injection, including lyophilisates
Line 3

synthesis of substances, manufacturing of soft and solid dosage forms
Line 4

manufacturing of injectable dosage form

Line 1

the release of medicines in pre-filled syringes
Line 2

manufacturing of medicines for injection, including lyophilisates
Line 3

synthesis of substances, manufacturing of soft and solid dosage forms
Line 4

manufacturing of injectable dosage form

For ten years, Petrovax has successfully confirmed compliance with the EU GMP certificate (Slovakia), which was first obtained in 2012

Every year the company successfully confirms compliance of production with international standards during audits of regulatory authorities for licensing and GMP certification, as well as inspections of international partners: Pfizer, Abbott, Boehringer Ingelheim.